Cipla to raise Rs 676 crore via QIP
Cipla is a pharmaceutical major of India and is planning to raise Rs 676 crore via a qualified institutional placement (QIP) route. The proceeds of this QIP issue would be used for capital expenditure The company had no plans for further fund raising in the near term. The company’s total debt is Rs 500 crore. Managing Director Amar Lulla informed the mrdia.
The board of directors of the company have approved the issuance of up to 2.56 crore equity shares at Rs 263.75 per equity share, thus garnering Rs 676 crore.
Related posts:
- Glenmark to raise Rs 300-350 cr via QIP Glenmark Pharmaceuticals informed SEBI that its board has decided to...
- Ackruti City to raise Rs 302 cr via QIP Real Estate company Ackruti City has informed SEBI that it...
- Cipla can test Rs 450: Gujral Ashwani Gujral (Technical Analyst), is of the view that Cipla...
- Nagarjuna Construction to raise Rs 367 cr via QIP Nagarjuna Construction Company (NCC) has informed the BSE that the...
- Sesa Goa : plans to raise Rs 6000 crore Sesa Goa is planning to raise Rs 6000 crore by...
Related posts brought to you by Yet Another Related Posts Plugin.
Activity